Foundation Medicine to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Foundation
Medicine, Inc. (NASDAQ:FMI) today announced that members of the
company’s management team will present at the following upcoming
investor conferences:

• Bank of America Merrill Lynch 2016 Healthcare Conference on Tuesday,
  May 10, 2016 at 10:00 a.m. P.T. in Las Vegas.
• UBS Global Healthcare Conference on Tuesday, May 24, 2016 at 3:00 p.m.
  E.T. in New York City.

Live, listen-only webcasts of the presentations may be accessed by
visiting the investors section of the company’s website at investors.foundationmedicine.com.
Replays of the webcasts will be available shortly after the conclusion
of the presentations and will be archived on the company’s website for
90 days.

About Foundation Medicine

Foundation Medicine (NASDAQ:FMI) is a molecular information company
dedicated to a transformation in cancer care in which treatment is
informed by a deep understanding of the genomic changes that contribute
to each patient’s unique cancer. The company’s clinical assays,
FoundationOne® for solid tumors and FoundationOne® Heme for hematologic
malignancies and sarcomas, provide a comprehensive genomic profile to
identify the molecular alterations in a patient’s cancer and match them
with relevant targeted therapies and clinical trials. Foundation
Medicine’s molecular information platform aims to improve day-to-day
care for patients by serving the needs of clinicians, academic
researchers and drug developers to help advance the science of molecular
medicine in cancer. For more information, please visit http://www.FoundationMedicine.com
or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine^® and FoundationOne^®
are registered trademarks of Foundation Medicine, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160428005148/en/